AXPH Stock Overview
Manufactures, markets, and distributes generic forms of human and animal health products in Egypt. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Alexandria Co. For Pharmaceuticals & Chemical Industries Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م317.85 |
| 52 Week High | ج.م330.00 |
| 52 Week Low | ج.م178.30 |
| Beta | -0.065 |
| 1 Month Change | 9.02% |
| 3 Month Change | 38.78% |
| 1 Year Change | 78.30% |
| 3 Year Change | 160.23% |
| 5 Year Change | 205.18% |
| Change since IPO | 875.01% |
Recent News & Updates
Recent updates
Shareholder Returns
| AXPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | -1.5% |
| 1Y | 78.3% | 31.9% | 28.7% |
Return vs Industry: AXPH exceeded the EG Pharmaceuticals industry which returned 27.9% over the past year.
Return vs Market: AXPH exceeded the EG Market which returned 27.5% over the past year.
Price Volatility
| AXPH volatility | |
|---|---|
| AXPH Average Weekly Movement | 6.3% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in EG Market | 8.8% |
| 10% least volatile stocks in EG Market | 3.3% |
Stable Share Price: AXPH has not had significant price volatility in the past 3 months compared to the EG market.
Volatility Over Time: AXPH's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Mahmoud Rizk | www.alexcopharma.net |
Alexandria Co. For Pharmaceuticals & Chemical Industries manufactures, markets, and distributes generic forms of human and animal health products in Egypt. It also offers medical appliances. The company is based in Alexandria, Egypt.
Alexandria Co. For Pharmaceuticals & Chemical Industries Fundamentals Summary
| AXPH fundamental statistics | |
|---|---|
| Market cap | ج.م1.59b |
| Earnings (TTM) | ج.م216.68m |
| Revenue (TTM) | ج.م1.77b |
7.3x
P/E Ratio0.9x
P/S RatioIs AXPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AXPH income statement (TTM) | |
|---|---|
| Revenue | ج.م1.77b |
| Cost of Revenue | ج.م1.37b |
| Gross Profit | ج.م395.18m |
| Other Expenses | ج.م178.50m |
| Earnings | ج.م216.68m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 43.34 |
| Gross Margin | 22.35% |
| Net Profit Margin | 12.26% |
| Debt/Equity Ratio | 0.1% |
How did AXPH perform over the long term?
See historical performance and comparisonDividends
9.4%
Current Dividend Yield69%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 08:35 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Alexandria Co. For Pharmaceuticals & Chemical Industries is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mohamed Antar Hassan | CI Capital Research |
| Mohamed Hamza | Pharos Research |